Press Releases

Mission Therapeutics Appoints Scientific Advisory Board

Mission Therapeutics Appoints Scientific Advisory Board

Cambridge, UK – 27 June 2017 – Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat serious diseases including mitochondrial diseases, neurodegeneration, inflammation and cancer, today... LEARN MORE
Mission Therapeutics Appoints Colin Goddard as Chairman

Mission Therapeutics Appoints Colin Goddard as Chairman

Michael Moore Transitions to Deputy Chairman CAMBRIDGE, UK – 5 December 2016 – Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative and other diseases,... LEARN MORE
Page 1 of 512345